Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Immunology

Background:

• Cell encapsulation is crucial for advancing transplantation and improving success rates.
• Effective devices require encapsulated cell viability, responsiveness, immune protection, and minimal foreign body response.

Purpose of the Study:

• To develop and evaluate a micro- and nanoporous thin-film cell encapsulation device using polycaprolactone (PCL).
• To assess the device's ability to protect encapsulated cells, maintain function, and allow for non-invasive monitoring.

Main Methods:

• Fabrication of micro- and nanoporous thin-film devices from polycaprolactone (PCL).
• In vitro assessment of immune cell invasion and cytokine-mediated cell death.
• In vitro testing of encapsulated cell function (e.g., insulin production).
• In vivo implantation of luciferase-positive MIN6 cells in allogeneic mouse models for up to 90 days.
• Long-term bioluminescent imaging for cell viability and device tracking.

Main Results:

• The PCL thin-film device demonstrated tunable porosity for selective immune protection.
• Encapsulated cells maintained viability and function, including glucose-stimulated insulin production.
• In vivo studies showed minimal foreign body response and rapid neovascularization around the implanted devices.
• Long-term bioluminescent imaging successfully monitored cell viability and device presence.

Conclusions:

• Polycaprolactone thin-film devices offer a promising platform for cell encapsulation.
• These devices facilitate immune isolation while allowing for cell function and non-invasive monitoring.
• The technology shows potential for advancing cell-based therapies and immune-isolation strategies in transplantation.